| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.79▲ | 5.79▲ | 5.80▲ | 5.80▼ | 5.87▼ |
| MA10 | 5.80▲ | 5.80▲ | 5.77▲ | 5.82▼ | 6.11▼ |
| MA20 | 5.79▲ | 5.81▲ | 5.82▲ | 5.91▼ | 6.44▼ |
| MA50 | 5.81▲ | 5.92▼ | 5.91▼ | 6.21▼ | 6.68▼ |
| MA100 | 5.89▲ | 5.92▼ | 5.93▼ | 6.47▼ | 6.55▼ |
| MA200 | 5.99▼ | 6.33▼ | 6.38▼ | 6.74▼ | 6.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.010▲ | 0.008▲ | 0.007▲ | -0.077▼ |
| RSI | 64.526▲ | 55.128▲ | 53.374▲ | 44.812▼ | 41.426▼ |
| STOCH | 30.556 | 46.667 | 62.363 | 24.306 | 14.322▼ |
| WILL %R | 0.000▲ | 0.000▲ | -21.311▲ | -82.609▼ | -87.783▼ |
| CCI | 318.087▲ | 195.622▲ | 136.493▲ | -62.072 | -79.269 |
|
Monday, March 30, 2026 05:01 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Monday, March 30, 2026 08:14 AM
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology, Inc. (Nasd ...
|
|
Monday, March 30, 2026 07:56 AM
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 5.65 | 6.02 | 5.65 | 5.77 | 2,911 |
| 01/04/26 | 5.70 | 5.9799 | 5.70 | 5.915 | 7,118 |
| 31/03/26 | 5.80 | 5.9637 | 5.75 | 5.75 | 2,916 |
| 30/03/26 | 5.70 | 5.9189 | 5.70 | 5.84 | 7,101 |
| 27/03/26 | 5.82 | 5.9015 | 5.65 | 5.74 | 11,340 |
| 26/03/26 | 5.80 | 5.845 | 5.745 | 5.79 | 8,098 |
| 25/03/26 | 5.825 | 5.875 | 5.80 | 5.80 | 7,291 |
| 24/03/26 | 5.81 | 5.9651 | 5.80 | 5.81 | 44,300 |
| 23/03/26 | 6.095 | 6.10 | 5.8041 | 5.96 | 3,324 |
| 20/03/26 | 6.21 | 6.2131 | 5.86 | 5.86 | 4,267 |
|
|
||||
|
|
||||
|
|